Bio-Rad Laboratories reported $7.6B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bio Techne USD 243.9M 17.7M Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Illumina USD 525M 374M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Laboratory Of America USD 3.39B 117.6M Sep/2026
Merck USD 10.75B 5.02B Sep/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.62B 34M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Siemens EUR 20.72B 3.12B Sep/2026
Standard Biotools USD 27.93M 2.63M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Tosoh JPY 287.29B 44.3B Sep/2026
Waters USD 527M 592M Jun/2026